chrisvoncsefalvay/vaers-outcomes huggingface dataset:
This spontaneous report was received from a physician via company representatives and from a support services director concerning a patient of unknown age and gender. The patient's medical history, concurrent conditions or concomitant therapies were not reported. On 15-DEC-2014, the patient was vaccinated with an improperly stored of GARDASIL "PFS 6x1.5mg/0.5ml w/o Sfty Syr" lot # J009098, expiration date 04-DEC-2015 (route and dose were not provided). This vaccine had three temperature excursions, one of 12 hours, another for 24 hours and another one for 8112 hours. The highest temperatures recorded were 46.8 degrees Fahrenheit (8.222222222 degrees Celsius), 47.5 degrees Fahrenheit (8.611111111 degrees Celsius) and 59.9 degrees Fahrenheit (15.5 Degrees Celsius) respectively. The vaccine status was reported as "in excursion". The vaccine storage criteria and type were reported as "refrigerator (R)". No adverse effects were reported. There was no product quality complaint involved. This is one of several reports received from the same reporter. Additional information has been requested.
Client complained of upset stomach, diarrhea, chills after receiving influenza vaccine. Not first flu vaccination.
Burnt eyes; Feeling tired; Headache; A spontaneous report was received from a 55-year-old female patient who received Moderna's COVID-19 vaccine (mRNA-1273) and experienced burnt eyes(eye irritation), headache (Headache) and feeling tired(fatigue).  The patient's medical history was not provided. Concomitant product use was not provided by the reporter.  On 15 Mar 2021, two days prior to the onset of the events, the patient received her first of the two planned vaccine doses of mRNA-1273 (Batch number: unknown) intramuscularly in the left non dominant arm for prophylaxis of COVID-19 infection.   On 17 Mar 2021, two days after receiving the vaccine, the patient had headache, burnt eyes and was feeling tired. Treatment for the events included paracetamol.  Action taken with mRNA-1273 in response to the events was not provided.  The outcome of the events, burnt eyes, headache and feeling tired, was unknown at the time of this report.; Reporter's Comments: Based on the current available information and temporal association between the use of the product and the start date of the events, a causal relationship cannot be excluded.
10-02-06 Pneumavax 23 vaccination sq to rt arm and Influenza vaccine IM lt arm in early am. Reported flu like symptoms and swelling and warmth to rt arm symptoms started at about 12 am.
This spontaneous report was received from a pharmacist refers to a patient of unknown age and gender. On 27-AUG-2013 the patient was vaccinated subcutaneous with an expired 0.65 ml dose of ZOSTAVAX lot # 672428/1599AA (exp. date 13-JAN-2013), subcutaneous. No adverse effect reported. This is one of several reports from the same source. Additional information has been requested.
Subsequent to receiving one dose of varicella virus vaccine live the pt was exposed to varicella. Approximately 10 days post exposure the pt developed a moderate case of breakthrough varicella. The pt sought unspecified medical attention. Subsequently the pt recovered. It was reported that two of the pts siblings had similar experiences. No further information is available.
Patient received a vaccine after 34 days in the fridge; No adverse event; Patient received a vaccine after 34 days in the fridge; This spontaneous case was reported by a pharmacist and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (Patient received a vaccine after 34 days in the fridge), PRODUCT STORAGE ERROR (Patient received a vaccine after 34 days in the fridge) and NO ADVERSE EVENT (No adverse event) in a 24-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 057A22A) for COVID-19 prophylaxis.     No Allergy No Diseases.     On 03-Jan-2023, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) .5 milliliter. On 03-Jan-2023,  after starting mRNA-1273 (Moderna COVID-19 Vaccine), the patient experienced EXPIRED PRODUCT ADMINISTERED (Patient received a vaccine after 34 days in the fridge). On an unknown date, the patient experienced PRODUCT STORAGE ERROR (Patient received a vaccine after 34 days in the fridge) and NO ADVERSE EVENT (No adverse event). At the time of the report, EXPIRED PRODUCT ADMINISTERED (Patient received a vaccine after 34 days in the fridge), PRODUCT STORAGE ERROR (Patient received a vaccine after 34 days in the fridge) and NO ADVERSE EVENT (No adverse event) outcome was unknown.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter considered NO ADVERSE EVENT (No adverse event) to be not related. No further causality assessments were provided for EXPIRED PRODUCT ADMINISTERED (Patient received a vaccine after 34 days in the fridge) and PRODUCT STORAGE ERROR (Patient received a vaccine after 34 days in the fridge).    Concomitant medication was not provided. Treatment medication information was not provided by the reporter.
No additional AEs were reported; 33 patients received improperly stored vaccines.; This spontaneous report was received from a licensed practical nurse and refers to a patient of unknown age and gender. The patient's concurrent conditions, concomitant therapies and medical history were not provided.  On 31-MAR-2022, the patient was vaccinated with improperly stored haemophilus b conjugate vaccine (meningococcal protein conjugate) (LIQUID PEDVAXHIB) 1 dose, lot # U026217, expiration date 02-NOV-2023 (exact dose number, route of administration and anatomical location were not provided) for prophylaxis (product storage error). The temperature excursion was 34.3 degrees Fahrenheit for 55 minutes. There were no previous temperature excursions. No additional adverse events were reported (no adverse event).  This is one of several cases received from the same reporter.; Sender's Comments:  US-009507513-2204USA001791: US-009507513-2204USA001621: US-009507513-2204USA001657: US-009507513-2204USA001730: US-009507513-2204USA001805: US-009507513-2204USA001839: US-009507513-2204USA001926: US-009507513-2204USA001952: US-009507513-2204USA001980: US-009507513-2204USA001994: US-009507513-2204USA001998: US-009507513-2204USA002003: US-009507513-2204USA002007: US-009507513-2204USA002009: US-009507513-2204USA002052: US-009507513-2204USA002055: US-009507513-2204USA002072: US-009507513-2204USA002073: US-009507513-2204USA002074: US-009507513-2204USA002075:
Pt right had was red and swollen, reaction to one shots 12x10cm induration.
I tested positive for COVID-19 on 02/13/2023. I had a cough, sore throat, headache. I called the provider the next day and prescribed PAXLOVID for 5 days. I tested negative for COVID-19 on 02/20/2023.
A report was received from a healthcare professional on 10/29/2003 who is a 65 year old male vaccinee who inadvertently received expired Fluvirin on 10/29/2003. On 10/29/2003 the vaccinee inadvertently received a dose of 2002-2003 expired Fluvirin.  The vaccinee had not experienced any adverse effects at the time of the report. There was insufficient information to determine the reporter's causality assessment. Update 1, 23 February 2004: Further information was received from a healthcare professional indicating that he experienced no adverse reaction. No follow up pending, all information received.
Wheeze/coughing/feeling like breathing obstructed. Also sore arm at injection site. Took a Benadryl at 5:00 PM. Symptoms gone next morning.
On 11/15/2018 at 3:30PM reported recurring "headache since that afternoon" (afternoon of vaccination, 11/13/2018); perhaps recurring due to relief by, then wearing off of, OTC analgesics. Also reported joint pain/ ache when turning over in bed, which started "that night, I guess." Requested that these symptoms be documented.
Hives; This is a spontaneous report from a contactable consumer (patient). A 57-year-old female patient received bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, Solution for injection), via an unspecified route on 02Mar2021 18:00 (Batch/Lot number was not reported) (at the age of 57-year-old) in arm left as an unknown, single dose for covid-19 immunisation. Medical history included cancer, and high blood pressure. No prior covid vaccination. The patient was not pregnant at the time of vaccination. The patient's concomitant medications were not reported. The patient previously received amoxicillin and experienced allergies. The patient broke out in hives on 03Mar2021, one day after injection and it lasted for two days. The patient used self-prescribed Benadryl as treatment. The patient was not tested for covid post vaccination. No other vaccine used in four weeks. The outcome of the event was resolved on 05Mar2021.  No follow-up attempts are possible; information about lot/batch number cannot be obtained.
Dizziness, almost fell out of the chair, had to be laid down on the ground. Known history of anxiety with needles.
TDAP vaccine administered in right deltoid. Symptoms began with the shoulder/clavicle aching and hurting. Deltoid muscle has ached since vaccine was given. First night was awakened by right had numb, tingling and burning, and was unable to close hand. After massaging area of injection and moving arm with circular motions, the sensations would go away but not completely, they would return after short periods of time. Sunday morning after another night of the same symptoms attempted to call DR who administrated vaccine, but they were closed. Sunday throughout the day had the same symptoms and was awakened several times by entire arm being asleep, fingers numb and burning sensation, right clavicle slightly burning and aching, and needing to get up to massage and exercise area. Called Monday morning to DR and explained all symptoms. Symptoms each day have been the same and some days strength of arm and fingers has declined. Tuesday around 1245pm was when I was contacted by Dr and said I was having a reaction to the vaccine and to take Tylenol, which I did take 1 tablet of 500 mg acetaminophen immediately. Symptoms have not since changed and every night I'm awakened and even now (5am Saturday morning) the symptoms are the same.
Patient got vaccine at 7:45PM 11/28/18 and at 8:15PM that same night she experienced what she described to me on 11/29/18 as severe shaking. She stated she also vomited several times and had diarrhea. She said for a short period of time, she felt that her tongue was swelling but that resolved shortly without the aid of any medication. She did not seek medical attention and stated she feels completely fine today - just tired. I asked if there were any other differences in her routine that day and she said no. She said that she has had flu shots in the past without an issue.
I received the second Pfizer COVID-19 booster on 7/18/2022 at around 4 PM. On 7/19/2022, I was so fatigued that I could barely get out of bed. I would get out of bed in short spurts, only to go back to bed afterwards. On 7/20/2022, I still had the fatigue, but it wasn't as severe. I was able to stay up for a little longer, and I slept for less time. I also had a headache. On 7/21/2022, I still felt fatigued and had a mild headache, but I didn't feel the need to stay in bed. On 7/22/2022, the fatigue was even less, and I was able to function.
About 24 hours after getting my COVID-19 vaccine I was having issues with being dizzy and vertigo. It was positional vertigo so as I am laying down if I move or turn the room will start to spin that will last for a few seconds. I have reached out to my ENT and they have me coming in to do some tests and check things out. The only thing that occurred was be getting the vaccine so I believe it is the cause of this positional vertigo. They are starting me out with physical therapy and will be doing some testing and things to figure out what is going on.
10 cm X 4 cm pinkish skin with mild swelling and induration proximally right deltoid.
Patient signed up for the Novavax vaccine for his primary series of vaccines.  It was his first vaccine in the series.  He was given the Pfizer Bivalent vaccine instead.  The error was noticed immediately and the patient was informed.  We called Dr. and he notified the Department of Health.  We told the patient that we would contact him as soon as we heard anything.
Patient went cross eyed an hour following these vaccinations and has been cross eyed since this date, November 14, 2019.
Patient has redness, swelling, and tenderness along upper right arm.  Experienced difficulty raising arm and mild sweating during the night after receiving PNEUMOVAX.
dose was given which had an expiration date of 14Jun2022; This case was reported by a other health professional via call center representative and described the occurrence of expired vaccine used in a 39-year-old female patient who received HAV (Havrix) (batch number X9A9B, expiry date 14th June 2022) for prophylaxis.   On 28th June 2022, the patient received the 1st dose of Havrix. On 28th June 2022, unknown after receiving Havrix, the patient experienced expired vaccine used. On an unknown date, the outcome of the expired vaccine used was unknown.  Additional Information: GSK Receipt Date: 29-JUN-2022 Reporter's comments:  The reporter stated that the patient was administered Havrix, which had an expiration date of 14th June 2022. At the time of reporting, dose had not been repeated. The vaccine administration facility was the same as primary reporter. The reporter consented to follow up. Additional Supportive Information: The patient received an expired dose of Havrix, which led to expired vaccine used.
Patient received one-dose of Pfizer COVID-19 vaccination on 3/10/21, subsequently tested positive for COVID-19 on 3/25/2021. Due to increased oxygen requirements, had to be admitted to the Health Care System on 3/26/2021. Patient was started on dexamethasone and remdesivir inpatient, but still developed worsening hypoxia requiring ICU admission to maintain adequate oxygenation. Highest oxygen requirement was 15 L/min. At the filing of this report, patient remains in the ICU on 6 L/min of oxygen via nasal cannula.
feeling flush & sick 4PM 14NOV96;arm was so painful couldn't sleep that noc;15NOV96 arm was swollen to 2x nl size;red & feverish;d/t pain radiating to fingers & up side of head (rt side) & local sx;pt saw MD;staph infect or rxn to vax;
Information has been received from a physician concerning a 27 year old female who on 10/3/06 was vaccinated with the first dose of HPV Vaccine (lot nor provided). On 10/12/06 the pt experienced a very sore arm. The physician advised the pt to take Advil and apply ice to the area. At the time of the report it was unk if the pt had recovered. Additional information has been requested. Follow up information received stated that as appriximately 03-NOV-2006 the patient recovered from the event.
Patient is a 62 y.o. female with a PMH significant for insulin-dependent diabetes mellitus, hypothyroidism, HTN, CKD stage III, anxiety, GERD, HLD, HTN, OSA on CPAP who presents as a transfer from hospital due to hypoxic respiratory failure due to COVID-19.
Abdominal pain an hour later headache severe pain in arm. Saturday morning fever, severe pain in arm and under the armpit could not eat or stand, pain in chest and back, chills in head and all over body felt like needle stabs, heart was racing bp 92/62. Severe swelling of site with pain and itching and redness 2 inches a cross my arm hot to the touch.
One pilll of Mycophenclate; A spontaneous report was received from a consumer concerning a 77 years-old female patient who received Moderna's COVID-19 vaccine (mRNA-1273) and received one pill of Mycophenclate.   The patient's medical history included chronic obstructive pulmonary disorder (COPD). Concomitant product use included unspecified blood pressure medication, unspecified inhaler, calcium levomefolate, unspecified cholesterol medications, lamotrigine, estradiol and levothyroxine sodium.  The patient received their first of two planned doses of mRNA-1273 (Lot # not provided) on an unknown date. On 23 Feb 2021, one day prior to the event, the patient received their second of two planned doses of mRNA-1273 (Lot number: not provided) intramuscularly for prophylaxis of COVID-19 infection.   On 24-Feb-2021, the patient had an appointment with pulmonologist for COPD. The pulmonologist added Mycophenclate which weakens immune system. The patient took one pill of mycophenclate on advice of pulmonologist.  Treatment information was not applicable.  Action taken with mRNA-1273 was not applicable.  The outcome of the event, one pill of mycophenclate, was unknown.; Reporter's Comments: This report refers to a case of Contraindicated product prescribed and taken by the patient 1 day after mRNA-1273 vaccine, lot # unknown with no associated Adverse Events.
I am health all the time without disease before vaccination. I got hearing loss in the right side suddenly in Jun I  got extrem pain all the body like myosities. 4 days can not stand up without the help of pain relife madicine.
First GHSV2 outbreak. Started one day after getting the vaccine. Was Prescribed acyclovir and having adverse reactions to the medication (bright red face and neck accompanied by itching)
My daughter did not sleep all night, had fever & chills. Got up early in am & fainted on tile floor in kitchen. She was easily aroused after fainting. Helped her to a chair Then she had a seizure. It was very short lasting, then she vomited. She was very weak for 2 hrs. after that & she continued to slowly consume water & crackers. After getting her to bed she slept for one hour.  Still too weak to go to bathroom alone. Improvement shown after 5 hrs of rest & fluids/some food.
six of the patients developed shingles within several days of receiving the vaccine; This is a spontaneous report received from a contactable consumer. This case is for the 4th patient. This consumer reported for an unknown female consumer (patient). A female patient of an unspecified age received first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, solution for injection, Batch/lot number and Expiration date was not provided), via an unspecified route of administration, on an unspecified date, as a single dose for covid-19 immunization. The patient's medical history and concomitant medications were not reported. Reporter stated that she read on the internet an article published specifically on 21Apr2021, "A Herpes Infection May Be Linked to the COVID Vaccine" from health.com. The researchers found that six of the patients developed shingles within several days of receiving the vaccine. All of the patients were women, and five of the reactions happened after the first vaccine dose.  Also said that it's triggered by the same virus that causes chickenpox. Reporter was asking if she should take a Shingles shot before getting the vaccine. reporter was surprised that we don't had any data on shingles or herpes since the Pfizer-BioNTech COVID-19 Vaccine was linked in the article and people had reported these and her daughter also experienced it. The outcome of the event was reported as unknown.  Information about Batch/Lot number requested.
Red and swollen at side of DTAP( Daptacel) given LD/IM yesterday. Given tylenol and using cold compresses-- itchy at sight on day two.
p/vax pt exp joint pain;chills;fever & hot/cold sweats; joint pain so severe could not undress or have anyone undress pt;problems walking due to joint pain;MD or ER visit was required;tx:advil;tylenol;fluids;condition is ongoing
Patient has syncope approximately more or less 5 minutes following administration of flu vaccine 1 & H1N1 vaccine.
They gave the booster on 27-Oct-2021 instead of the additional dose; This spontaneous case was reported by a pharmacist and describes the occurrence of ACCIDENTAL UNDERDOSE (They gave the booster on 27-Oct-2021 instead of the additional dose) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     The patient's past medical history included Heart transplant.   On 12-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 16-Apr-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 27-Oct-2021, received third dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 27-Oct-2021,  after starting mRNA-1273 (Moderna COVID-19 Vaccine), the patient experienced ACCIDENTAL UNDERDOSE (They gave the booster on 27-Oct-2021 instead of the additional dose). At the time of the report, ACCIDENTAL UNDERDOSE (They gave the booster on 27-Oct-2021 instead of the additional dose) outcome was unknown.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   No concomitant medications reported. No treatment medications reported.   Most recent FOLLOW-UP information incorporated above includes: On 22-Feb-2022: Follow-up received contains Non-significant information.
Since getting this booster I have felt chronically tired. My sleep quality has been poor with vivid dreams. I am sleeping 1 -2 hours longer than normal. My level of anxiety is higher than normal. The fatigue was worse in the 2 weeks after the booster, but is still has not gone away.
Suffered 2 strokes; kidney stone surgery; A spontaneous report was received from a consumer concerning a 62 year-old, female patient, who received Moderna's COVID-19 vaccine (mRNA-1273) and experienced cerebrovascular accident,and renal stone surgery.   The patient's medical history was not provided., included allergy to cefaclor and hereditary hemorrhagic telangiectasia.Concomitant medications reported included Atrovastin, Aspirin, Clopidogrel, Olicolic oil.  On 21 Jan 2021 , approximately 28 days  prior to the onset of the events, the patient received the first of two planned doses of mRNA-1273 (Lot number: 032120A) via unknown route in an unknown site for prophylaxis of COVID-19 infection. Before the scheduled second dose of Moderna Vaccination patient developed adverse events.  On 16 Feb 2021, patient had surgery for kidney stone. On 17 Feb 2021 she developed a stroke and again on 26 Feb 2021 she developed second stroke.The event stroke was considered serious and medically significant.  The treatment taken for the events was reported as unknown. Action taken with mRNA-1273 in response to the events was unknown..  The outcomes of the events were considered as unknown.; Reporter's Comments: Based on the current available information and temporal association between the use of the product and the start date of the events, a causal relationship cannot be excluded.
Patient was supposed to get a booster dose or 0.25ml and received a dose of 0.5ml.
Chills, Fatigue, Muscle Aches, Sore Arm, Hot at site of injection, Mild Headache, Malaise.
Severe dysautonomia symptoms the night of, and lesser dysautonomia on day two and three (and counting).
Vaccine administered 2/20/15 (PNEUMOVAX 23). Rash and chills on 2/21/15. Fever (100, with patient's baseline 97-98) on 2/22/15. Seen in the office on 2/23/15 with the arm red, itchy, swollen and warm (puncture site clear, with area of erythema and warmth just distally, measuring 21cmx7cm, with extension to the axilla. Reaction: right arm.
Starting 6hrs after injection 101 degree fever, coupled with headache, fatigue, and nausea. Most symptoms ceased after 24hrs after the injection. Small aches and Minor fatigued persisted for another 24 hours.